NCT06223308 2024-01-25
A Study Evaluating the Safety and Efficacy of HB0028 in Subjects With Advanced Solid Tumors
Shanghai Huaota Biopharmaceutical Co., Ltd.
Phase 1/2 Unknown
Shanghai Huaota Biopharmaceutical Co., Ltd.
Peking University Third Hospital
Shenzhen Geno-Immune Medical Institute
Shenzhen Geno-Immune Medical Institute
All India Institute of Medical Sciences
Julius-Maximilians University